**Non-Disclosure Agreement**

The Hague, July 9, 2025

Re: Non-Disclosure Agreement Project Bluewhale

We have been informed of your (AXI Holdings Services BV, with registered
office at Molenweg 107, 2830 Willebroek, registered with the Crossroads
Bank for Enterprises under number 1002.091.063 (RLE Antwerp, division
Mechelen) hereinafter: the "**Undersigned**") possible interest in
acquiring "Bluewhale" (the "**Company**"). Therefore you have requested
us to disclose information in respect of the Company.

In consideration of us agreeing to make available to you certain
information, by your signature of a copy of this letter you agree as
follows:

**A. Confidentiality**

This letter and the commitments under this letter are hereinafter
referred to as the "**Undertaking**".

The Undersigned, each of its holding companies and subsidiaries and each
subsidiary of each of its holding companies and their officers,
directors, employees, professional advisers, providers of finance,++
[shareholders, potential syndicate members]{.mark} ++and auditors
receiving or reviewing the Confidential Information (as defined below),
or any part thereof, are hereinafter referred to as the
"**Recipients**".

The term "**Confidential** **Information**" means any documentation or
information provided on or after the date hereof in whatever form to the
Recipients by or on behalf of the Company or other involved party (such
as management or shareholders of the Company), in connection with the
(contemplated) transaction ("**Transaction**"), including, but not
limited to details of any involved party. Confidential Information
excludes any information that:

a)  at the time of its disclosure it was already in the public domain;

b)  is developed independently by the Undersigned and/or Recipients;

c)  after disclosure it comes into the public domain for any other
    > reason than your failure or failure on the part of any Recipients
    > to comply with the terms of this Undertaking; and/or

d)  it was already lawfully in your possession prior to such disclosure.

The Undersigned acknowledges and agrees that the Confidential
Information may be disclosed on a non-exclusive basis and is disclosed
subject to the disclaimer attached hereto as [Schedule 1]{.underline}
and that it must be treated confidential and therefore the Undersigned
shall:

a)  only use the Confidential Information for the purpose to investigate
    the Transaction by the Undersigned, provided that the Company
    acknowledges that the Undersigned, and its Recipients, make, and
    have made investments in a variety of markets and that the review of
    Confidential Information may enhance Undersigned's', and its
    Recipients' understanding of the markets in which the Company may
    now or in the future, compete as a principal investor or operator
    ("**Know-How**") and that such Know-How will not in and of itself be
    considered a violation of this letter;

b)  disclose (a part of) the Confidential Information only to other
    Recipients, provided that (i) each of the Recipients has given a
    statement in writing to the Undersigned to accept and fully comply
    vis-Ã -vis the Undersigned and, the Company with the obligations of
    the Undersigned under this Undertaking as its own ++[, except where
    expressly stated otherwise in this Undertaking,]{.mark}++ and (ii)
    that none of the Recipients will be entitled to make public or
    disclose the Confidential Information otherwise (to other persons);

c)  keep the number of Recipients as limited as possible;

d)  at any time direct that the Confidential Information will not become
    public or is disclosed to any other person than the Recipients, in
    whatever manner, unless and to the extent required by law or by the
    rules and regulations of any stock exchange or regulatory body, in
    which case, to the extent permitted by law or regulation and
    reasonably practicable, only the required disclosures will be made
    after consultation of the Company, and the Undersigned shall use its
    best endeavours to obtain a confidentiality undertaking by the
    authority or person to which it must be disclosed;

e)  on first written request by the Company, the Undersigned will within
    five business days at its option (i) return or (ii) destroy all
    Confidential Information and as far a reasonable practicable,
    permanently destroys all other data carriers, electronically, in
    writing or otherwise, carrying Confidential Information or making
    reference thereto ++, [except for (i) Confidential Information and
    elaborations thereof as have been saved to electronic carriers under
    automatic data archiving or data security procedures, (ii) reports,
    notes or other materials prepared by or on behalf of the Undersigned
    which incorporate Confidential Information (the "**Secondary
    Information**"), provided that the Secondary Information is kept
    confidential in accordance with the terms of this Undertaking,
    and (iii) Confidential Information which is required to be retained
    for the purposes of complying with any mandatory judicial,
    governmental, supervisory or regulatory order or for audit or
    compliance purposes]{.mark};++ and

f)  as soon as reasonably practicable notify the Company upon discovery
    of any unauthorised use or disclosure of Confidential Information
    and/or any breach under this Undertaking.

g)  during a period of \--24 \-- ++[12]{.mark}++ (++t[welve]{.mark}++
    \--twenty four\--) months starting on the date of this Undertaking,
    notify and \--[cause]{.mark} \-- ++use its best efforts to cause++
    each of the Recipients not (i) to contact (by whatever means) the
    Company, its direct or indirect shareholders, their management,
    their current or former key employees, agents, advisors, auditors or
    representatives in connection with the Transaction, except in the
    ordinary course of business and unrelated to the Transaction, and
    except to the extent agreed otherwise between the Company and (ii)
    to induce any of the suppliers or customers of the Company to change
    or terminate their business relationship with the Company, except in
    the ordinary course of business and unrelated to the Transaction;

h)  other than (i) pursuant to a *bona fide* recruitment advertisement
    not specifically directed at any employee of the Company \--which is
    published in a national, regional or trade newspaper, magazine or on
    the Internet, \--and which takes place without any other form of
    accompanying solicitation or enticement, or (ii) unsolicited
    approaches by the Company's employees not initiate or have
    discussions with respect to prospective employment (conditions) of
    any directors, officers or key employees of the Company during a
    period of ++12++ \--24\-- (++t[welve]{.mark}++ \--twenty four\--)
    months starting on the date of this Undertaking.

The Undersigned acknowledges and agrees to keep confidential and not
disclose to anyone except the Recipients the fact that the Confidential
Information has been made available or that discussions or negotiations
are taking place or have taken place between us in connection with the
Transaction.

All Confidential Information is and shall remain the sole and exclusive
property of the Company. By disclosing information to the Recipients,
the Company does not grant any express or implied right to the
Recipients to or under the Company patents, copyrights, trademarks, or
trade secret information.

**B. Miscellaneous**

This Undertaking constitutes the entire agreement between the Company
and the Undersigned in respect of the sharing of Confidential
Information, and supersedes any previous agreement, whether express or
implied, regarding hereto. The terms of this Undertaking and the
obligations hereunder may only be amended or modified by written
agreement between the Company and the Undersigned.

The obligations under this Confidentiality Agreement will be continuing
throughout the evaluation of the Company and will survive completion of
the negotiations regarding the Transaction, whether or not the
Transaction is implemented, for a period of 24 (twenty four) months from
the date of this Confidentiality Agreement.

++[This undertaking does not impose an obligation on the Undersigned to
enter into definitive agreements regarding the Transaction]{.mark}. ++

This Undertaking is governed by --Dutch\-- ++[Belgian]{.mark} ++law and
the++ [courts of Antwerp, division Mechelen]{.mark}++ \-- Court\-- of
\--Amsterdam \--will have exclusive jurisdiction to settle any dispute
in first instance arising out of or in connection with this Undertaking
(including a dispute relating to any non-contractual obligations arising
out of or in connection with either this letter of the negotiation of
the transaction contemplated by this letter).

The Undersigned hereby confirms its acceptance of the Undertaking as
well as the disclaimer which is attached hereto as [Schedule
1]{.underline}.

[Schedule 1: Disclaimer]{.underline}

1.  The Confidential Information has only been made available to
    professional investors who are deemed to be sufficiently expert
    and/or experienced to understand the aspects and risks involved in
    making the preparations for and completing an acquisition in
    general, and in particular an acquisition of the Company. It is
    expected that the Undersigned will obtain expert advice where and
    when needed.

2.  The Confidential Information will not purport to be all-inclusive,
    or to contain all the information that a prospective purchaser of
    the Company (or part thereof) may desire in deciding whether or not
    to enter into the Transaction.

3.  All Confidential Information is provided \"**AS IS**\" and the
    Company makes no warranty regarding the accuracy or reliability of
    such information. The Company will not be liable for any expenses or
    losses incurred or any action undertaken by the Recipients as a
    result of the receipt of Confidential Information. The entire risk
    arising out of the use of the Confidential Information remains with
    the Recipients.

4.  

5.  \--With respect to all matters set forth in the Undertaking, it is
    understood that: (i) this Undertaking sets forth the intentions of
    the Company to grant information to the Recipients and that any
    legal obligations with respect to a possible Transaction, shall be
    only as set forth in the possible Transaction documents, when and if
    executed by the Parties, and (ii) that no Party shall be responsible
    for any claims or liability hereby in the event the possible
    Transaction is not so executed and delivered, for whatever
    reason.\-- In furnishing the Confidential Information, neither the
    Company nor the shareholders of the Company undertake any obligation
    to provide the Undersigned with access to any additional
    information, to update the Confidential Information or to correct
    any inaccuracies in the Confidential Information. There will be no
    obligation to provide equal treatment to any prospective purchaser
    in connection with the Transaction.

6.  The Undersigned must make its own independent investigation and
    evaluation of the Confidential Information.

7.  No written or oral information made available to the Undersigned
    does constitute an offer or invitation for the sale or purchase of
    any interest in the Company (or any part hereof) or does constitute
    any form of commitment or recommendation.

8.  The Undersigned shall bear any and all costs incurred in connection
    with its investigation and evaluation of the Confidential
    Information and/or the Transaction.

Please acknowledge your agreement to the above by signing and returning
this letter and the disclaimer.

For acceptance of the non-disclosure agreement and with the disclaimer
(schedule 1):

Place and date: Willebroek, \[[XX]{.mark}\] July 2025

Company name: Axi Holdings Services BV

Name: Magnolia Management BV, permanently represented by Giel-Jan Triest

Title: Special proxy holder
